Abraham Rami Tzafriri
Abraham Rami Tzafriri
Director of Research and Innovation, CBSET Inc.
Verified email at
Cited by
Cited by
Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents
B Balakrishnan, AR Tzafriri, P Seifert, A Groothuis, C Rogers, ...
Circulation 111 (22), 2958-2965, 2005
Michaelis-Menten kinetics at high enzyme concentrations
AR Tzafriri
Bulletin of mathematical biology 65 (6), 1111-1129, 2003
Luminal flow patterns dictate arterial drug deposition in stent-based delivery
VB Kolachalama, AR Tzafriri, DY Arifin, ER Edelman
Journal of Controlled Release 133 (1), 24-30, 2009
Mortality and paclitaxel-coated devices: an individual patient data meta-analysis
KJ Rocha-Singh, S Duval, MR Jaff, PA Schneider, GM Ansel, SP Lyden, ...
Circulation 141 (23), 1859-1869, 2020
Stent elution rate determines drug deposition and receptor-mediated effects
AR Tzafriri, A Groothuis, GS Price, ER Edelman
Journal of controlled release 161 (3), 918-926, 2012
Innervation patterns may limit response to endovascular renal denervation
AR Tzafriri, F Mahfoud, JH Keating, PM Markham, A Spognardi, G Wong, ...
Journal of the American College of Cardiology 64 (11), 1079-1087, 2014
The total quasi-steady-state approximation is valid for reversible enzyme kinetics
AR Tzafriri, ER Edelman
Journal of theoretical biology 226 (3), 303-313, 2004
Diffusion‐limited binding explains binary dose response for local arterial and tumour drug delivery
AR Tzafriri, AD Levin, ER Edelman
Cell proliferation 42 (3), 348-363, 2009
Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis
AR Tzafriri, F Garcia-Polite, B Zani, J Stanley, B Muraj, J Knutson, ...
Journal of Controlled Release 264, 203-210, 2017
Lesion complexity determines arterial drug distribution after local drug delivery
AR Tzafriri, N Vukmirovic, VB Kolachalama, I Astafieva, ER Edelman
Journal of Controlled Release 142 (3), 332-338, 2010
Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug
WC Carlyle, JB McClain, AR Tzafriri, L Bailey, BG Zani, PM Markham, ...
Journal of controlled release 162 (3), 561-567, 2012
Mathematical modeling of diffusion-mediated release from bulk degrading matrices
AR Tzafriri
Journal of controlled release 63 (1-2), 69-79, 2000
Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy
VB Kolachalama, SD Pacetti, JW Franses, JJ Stankus, HQ Zhao, T Shazly, ...
Circulation 127 (20), 2047-2055, 2013
Quasi-steady-state kinetics at enzyme and substrate concentrations in excess of the Michaelis–Menten constant
AR Tzafriri, ER Edelman
Journal of Theoretical Biology 245 (4), 737-748, 2007
Mathematical modeling and optimization of drug delivery from intratumorally injected microspheres
AR Tzafriri, EI Lerner, M Flashner-Barak, M Hinchcliffe, E Ratner, ...
Clinical Cancer Research 11 (2), 826-834, 2005
Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension
AR Tzafriri, JH Keating, PM Markham, AM Spognardi, JR L. Stanley, ...
Science translational medicine 7 (285), 285ra65-285ra65, 2015
Reaction diffusion model of the enzymatic erosion of insoluble fibrillar matrices
AR Tzafriri, M Bercovier, H Parnas
Biophysical journal 83 (2), 776-793, 2002
Stat5 signaling specifies basal versus stress erythropoietic responses through distinct binary and graded dynamic modalities
E Porpiglia, D Hidalgo, M Koulnis, AR Tzafriri, M Socolovsky
Public Library of Science 10 (8), e1001383, 2012
A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma
L Indolfi, M Ligorio, DT Ting, K Xega, AR Tzafriri, F Bersani, N Aceto, ...
Biomaterials 93, 71-82, 2016
Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics
AR Tzafriri, SA Parikh, E ER
Journal of Controlled Release, 2019
The system can't perform the operation now. Try again later.
Articles 1–20